approval
saveZEPBOUND (TIRZEPATIDE) — FDA approval
community read0 votes
Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalFeb 25, 2026 · 227d ago
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalJan 20, 2026 · 263d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalJan 20, 2026 · 263d ago
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalJan 7, 2026 · 276d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalJan 7, 2026 · 276d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalDec 19, 2025 · 295d ago
- approvalZEPBOUND (TIRZEPATIDE) — FDA approvalSep 25, 2025 · 380d ago
- approvalMOUNJARO (TIRZEPATIDE) — FDA approvalSep 25, 2025 · 380d ago
same company · ±60 days · 5
- approvalmirikizumab: OMVOH (MIRIKIZUMAB-MRKZ) — FDA approvalJan 15, 2025
- approvalmirikizumab: OMVOH (MIRIKIZUMAB-MRKZ) — FDA approvalJan 15, 2025
- approvalZEPBOUND: ZEPBOUND (TIRZEPATIDE) — FDA approvalDec 20, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalDec 18, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalDec 18, 2024
comments(0)
5-min edit window · permanent after that